小主动脉瓣环扩大术后人工瓣膜-患者不匹配的临床影响
本研究回顾性分析2011-2024年169例因小主动脉瓣环行主动脉瓣环扩大(AAE)下外科主动脉瓣置换(SAVR)的成人患者,评估残余人工瓣膜-患者不匹配(PPM)的临床影响。结果显示PPM发生率为14.8%(中度14.2%,重度0.6%),残余PPM未显著影响早期术后结局、中期生存率或瓣膜血流动力学。
要点
- AAE后PPM发生率较低(14.8%),以中度为主。
- 残余PPM未增加早期卒中或30天死亡风险。
- PPM与无PPM组中期生存和心衰住院率相似。
核心结论
- 在小主动脉瓣环行SAVR联合AAE的患者中,PPM发生率低,且残余PPM未对早期结局、中期生存或瓣膜血流动力学产生不良影响。
研究设计与样本
- 回顾性队列研究,纳入2011-2024年间前瞻性维护机构数据库中所有因小主动脉瓣环行SAVR联合AAE的成人患者,共169例。
主要发现
- PPM发生于25例(14.8%),其中中度24例(14.2%),重度1例(0.6%)。
- 早期结局:术后卒中PPM组0例(0%) vs. 无PPM组3例(2.1%),p > 0.999;30天死亡率PPM组1例(4.0%) vs. 无PPM组5例(3.5%),p > 0.999。
- 4年随访:生存(HR 0.94,95%CI 0.40-2.21,p = 0.896)和免于心衰住院(HR 1.16,95%CI 0.45-2.95,p = 0.760)两组相似。
- 超声心动图趋势:随访期间LVEF(p = 0.123)和平均跨瓣压差(p = 0.879)无差异。
关键数值与推荐
- PPM定义基于已发表参考表推导的指数化有效瓣口面积阈值。
- 术后瓣膜尺寸中位数为23 mm(21-25)。
- 术前平均跨瓣压差为45.0 mmHg(36.8-57.2)。
临床怎么用
- 对于小主动脉瓣环患者,SAVR联合AAE可有效降低PPM发生率。
- 术后残余PPM(尤其是中度)可能无需额外干预,但需个体化评估。
局限性
- 回顾性研究设计。
- 样本量较小(169例)。
- PPM定义基于参考表而非直接测量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Aortic annular enlargement (AAE) during surgical aortic valve replacement (SAVR) is performed to facilitate implantation of larger prostheses in patients with small aortic annuli and mitigate prosthesis-patient mismatch (PPM). However, the clinical impact of residual PPM after AAE remains uncertain. METHODS: All adult patients who underwent SAVR with AAE for small aortic annuli were retrospectively identified from a prospectively maintained institutional database (2011-2024). PPM was defined based on indexed effective orifice area thresholds derived from published reference tables. The primary outcome was all-cause mortality, and secondary outcomes included heart failure (HF) hospitalization, and longitudinal echocardiographic performance. RESULTS: A total of 169 patients were identified (age 68 years [61-73], 119 female [70.4%]). Median STS risk was 2% [1-4%], and preoperative mean gradient was 45.0 mmHg [36.8-57.2]. Overall median valve size after AAE was 23 mm (21-25), and PPM occurred in 25 patients (14.8%), including 24 (14.2%) with moderate and 1 (0.6%) with severe PPM. Early outcomes were comparable between PPM and no-PPM groups: postoperative stroke 0 (0%) vs. 3 (2.1%, p > 0.999), and 30-day mortality 1 (4.0%) vs. 5 (3.5%, p > 0.999). Over 4 years follow-up, survival (HR 0.94, 95%CI 0.40-2.21, p = 0.896) and freedom from HF hospitalization (HR 1.16, 95%CI 0.45-2.95, p = 0.760) were similar. Echocardiographic trends showed no differences in LVEF (p = 0.123) or mean gradient (p = 0.879) during follow-up. CONCLUSIONS: In patients with small aortic annuli undergoing SAVR with annular enlargement, the incidence of PPM was low, and residual PPM did not adversely impact early postoperative outcomes, mid-term survival, or valve hemodynamics.
引用
- Jacquemyn, Imran, Serna-Gallegos, et al. Prosthesis-patient mismatch after surgical aortic valve replacement with aortic annular enlargement in small aortic annuli. Interdiscip Cardiovasc Thorac Surg. 2026. PMID: 42937128. doi:10.1093/icvts/ivag285
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。